MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000518854

Медицинская библиотека · Respiration; international review of thoracic diseases · 2021

Fatigue and Dyspnoea as Main Persistent Post-COVID-19 Symptoms in Previously Hospitalized Patients: Related Functional Limitations and Disability.

Fernández-de-Las-Peñas César, Palacios-Ceña Domingo, Gómez-Mayordomo Víctor, Palacios-Ceña María, Rodríguez-Jiménez Jorge, de-la-Llave-Rincón Ana I, Velasco-Arribas María, Fuensalida-Novo Stella, Ambite-Quesada Silvia, Guijarro Carlos, Cuadrado María L, Florencio Lidiane L, Arias-Navalón José A, Ortega-Santiago Ricardo, Elvira-Martínez Carlos M, Molina-Trigueros Luis J, Torres-Macho Juan, Sebastián-Viana Tomas, Canto-Diez María Gabriela, Cigarán-Méndez Margarita, Hernández-Barrera Valentín, Arendt-Nielsen Lars

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

Multicentre studies focussing on specific long-term post-COVID-19 symptoms are scarce.

OBJECTIVE

The aim of this study was to determine the levels of fatigue and dyspnoea, repercussions on daily life activities, and risk factors associated with fatigue or dyspnoea in COVID-19 survivors at long term after hospital discharge.

METHODS

Age, gender, height, weight, symptoms at hospitalization, pre-existing medical comorbidity, intensive care unit admission, and the presence of cardio-respiratory symptoms developed after severe acute respiratory syndrome coronavirus 2 infection were collected from patients who recovered from COVID-19 at 4 hospitals in Madrid (Spain) from March 1 to May 31, 2020 (first COVID-19 wave). The Functional Impairment Checklist was used for evaluating fatigue/dyspnoea levels and functional limitations.

RESULTS

A total of 1,142 patients (48% women, age: 61, standard deviation [SD]: 17 years) were assessed 7.0 months (SD 0.6) after hospitalization. Fatigue was present in 61% patients, dyspnoea with activity in 55%, and dyspnoea at rest in 23.5%. Only 355 (31.1%) patients did not exhibit fatigue and/or dyspnoea 7 months after hospitalization. Forty-five per cent reported functional limitations with daily living activities. Risk factors associated with fatigue and dyspnoea included female gender, number of pre-existing comorbidities, and number of symptoms at hospitalization. The number of days at hospital was a risk factor just for dyspnoea.

CONCLUSIONS

Fatigue and/or dyspnoea were present in 70% of hospitalized COVID-19 survivors 7 months after discharge. In addition, 45% patients exhibited limitations on daily living activities. Being female, higher number of pre-existing medical comorbidities and number of symptoms at hospitalization were risk factors associated to fatigue/dyspnoea in COVID-19 survivors 7 months after hospitalization.

Для цитирования: Fernández-de-Las-Peñas César, Palacios-Ceña Domingo, Gómez-Mayordomo Víctor, Palacios-Ceña María, Rodríguez-Jiménez Jorge, de-la-Llave-Rincón Ana I, Velasco-Arribas María, Fuensalida-Novo Stella, Ambite-Quesada Silvia, Guijarro Carlos, Cuadrado María L, Florencio Lidiane L, Arias-Navalón José A, Ortega-Santiago Ricardo, Elvira-Martínez Carlos M, Molina-Trigueros Luis J, Torres-Macho Juan, Sebastián-Viana Tomas, Canto-Diez María Gabriela, Cigarán-Méndez Margarita, Hernández-Barrera Valentín, Arendt-Nielsen Lars. Fatigue and Dyspnoea as Main Persistent Post-COVID-19 Symptoms in Previously Hospitalized Patients: Related Functional Limitations and Disability.. Respiration; international review of thoracic diseases. 2021. DOI: 10.1159/000518854.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.